Diagnosis of Neonatal Sepsis: The Role of Inflammatory Markers

Overview

Journal Front Pediatr

Specialty Pediatrics

Date 2022 Mar 29

PMID 35345614

Authors

Julia Eichberger

Elisabeth Resch

Bernhard Resch

Affiliations

Soon will be listed here.

Abstract

This is a narrative review on the role of biomarkers in the diagnosis of neonatal sepsis. We describe the difficulties to obtain standardized definitions in neonatal sepsis and discuss the limitations of published evidence of cut-off values and their sensitivities and specificities. Maternal risk factors influence the results of inflammatory markers as do gestational age, the time of sampling, the use of either cord blood or neonatal peripheral blood, and some non-infectious causes. Current evidence suggests that the use of promising diagnostic markers such as CD11b, CD64, IL-6, IL-8, PCT, and CRP, either alone or in combination, might enable clinicians discontinuing antibiotics confidently within 24-48 h. However, none of the current diagnostic markers is sensitive and specific enough to support the decision of withholding antibiotic treatment without considering clinical findings. It therefore seems to be justified that antibiotics are often initiated in ill term and especially preterm infants. Early markers like IL-6 and later markers like CRP are helpful in the diagnosis of neonatal sepsis considering the clinical aspect of the neonate, the gestational age, maternal risk factors and the time (age of the neonate regarding early-onset sepsis) of blood sampling.

Citing Articles

Assessing the diagnostic potential of 16SrRNA gene for neonatal sepsis: A tertiary care hospital study in South India.

Yadav A, Nataraj S, Sharma R, Vishwanath P, Doddaiah N, Murthy S Med J Armed Forces India. 2025; 80(6):695-701.

PMID: 39990530 PMC: 11842920. DOI: 10.1016/j.mjafi.2023.10.003.

Biomarker Potential of Interleukin-6 in Differentiating Necrotizing Enterocolitis from Late-Onset Sepsis in Neonates Born Preterm.

Imren C, de Groot V, Keyzer-Dekker C, Reiss I, Willemsen S, Vermeulen M J Pediatr Clin Pract. 2025; 15:200138.

PMID: 39958363 PMC: 11824627. DOI: 10.1016/j.jpedcp.2024.200138.

Diagnosis of neonatal and adult sepsis using a Serum Amyloid A lateral flow test.

Nowak J, Ssanyu J, Namiiro F, Mountford N, Parducci A, Domijan K PLoS One. 2025; 20(2):e0314702.

PMID: 39937751 PMC: 11819581. DOI: 10.1371/journal.pone.0314702.

Neonatal Sepsis: A Comprehensive Review.

Kariniotaki C, Thomou C, Gkentzi D, Panteris E, Dimitriou G, Hatzidaki E Antibiotics (Basel). 2025; 14(1).

PMID: 39858292 PMC: 11761862. DOI: 10.3390/antibiotics14010006.

Influenza Immunization in Very-Low-Birth-Weight Infants: Epidemiology and Long-Term Outcomes.

Dammann M, Kraft H, Stichtenoth G, Hanke K, Zemlin M, Soler Wenglein J Vaccines (Basel). 2025; 13(1).

PMID: 39852821 PMC: 11769184. DOI: 10.3390/vaccines13010042.

References

Achten N, Klingenberg C, Benitz W, Stocker M, Schlapbach L, Giannoni E . Association of Use of the Neonatal Early-Onset Sepsis Calculator With Reduction in Antibiotic Therapy and Safety: A Systematic Review and Meta-analysis. JAMA Pediatr. 2019; 173(11):1032-1040. PMC: 6724419. DOI: 10.1001/jamapediatrics.2019.2825. View

Delanghe J, Speeckaert M . Translational research and biomarkers in neonatal sepsis. Clin Chim Acta. 2015; 451(Pt A):46-64. DOI: 10.1016/j.cca.2015.01.031. View

Shi J, Tang J, Chen D . Meta-analysis of diagnostic accuracy of neutrophil CD64 for neonatal sepsis. Ital J Pediatr. 2016; 42(1):57. PMC: 4897921. DOI: 10.1186/s13052-016-0268-1. View

Doellner H, Arntzen K, Haereid P, Aag S, Austgulen R . Interleukin-6 concentrations in neonates evaluated for sepsis. J Pediatr. 1998; 132(2):295-9. DOI: 10.1016/s0022-3476(98)70448-2. View

Messer J, Eyer D, Donato L, Gallati H, Matis J, Simeoni U . Evaluation of interleukin-6 and soluble receptors of tumor necrosis factor for early diagnosis of neonatal infection. J Pediatr. 1996; 129(4):574-80. DOI: 10.1016/s0022-3476(96)70123-3. View

Madsen-Bouterse S, Romero R, Tarca A, Kusanovic J, Espinoza J, Kim C . The transcriptome of the fetal inflammatory response syndrome. Am J Reprod Immunol. 2010; 63(1):73-92. PMC: 3437779. DOI: 10.1111/j.1600-0897.2009.00791.x. View

Hashem H, El Masry S, Mokhtar A, Ismail E, AbdelAal N . Valuable Role of Neutrophil CD64 and Highly Sensitive CRP Biomarkers for Diagnostic, Monitoring, and Prognostic Evaluations of Sepsis Patients in Neonatal ICUs. Biomed Res Int. 2020; 2020:6214363. PMC: 7429763. DOI: 10.1155/2020/6214363. View

Benitz W, Han M, Madan A, Ramachandra P . Serial serum C-reactive protein levels in the diagnosis of neonatal infection. Pediatrics. 1998; 102(4):E41. DOI: 10.1542/peds.102.4.e41. View

Berardi A, Buffagni A, Rossi C, Vaccina E, Cattelani C, Gambini L . Serial physical examinations, a simple and reliable tool for managing neonates at risk for early-onset sepsis. World J Clin Pediatr. 2016; 5(4):358-364. PMC: 5099587. DOI: 10.5409/wjcp.v5.i4.358. View

10.

Hofer N, Kothari R, Morris N, Muller W, Resch B . The fetal inflammatory response syndrome is a risk factor for morbidity in preterm neonates. Am J Obstet Gynecol. 2013; 209(6):542.e1-542.e11. DOI: 10.1016/j.ajog.2013.08.030. View

11.

Athhan F, Akagunduz B, Genel F, Bak M, Can D . Procalcitonin: a marker of neonatal sepsis. J Trop Pediatr. 2002; 48(1):10-4. DOI: 10.1093/tropej/48.1.10. View

12.

Meem M, Modak J, Mortuza R, Morshed M, Islam M, Saha S . Biomarkers for diagnosis of neonatal infections: A systematic analysis of their potential as a point-of-care diagnostics. J Glob Health. 2012; 1(2):201-9. PMC: 3484777. View

13.

Layseca-Espinosa E, Perez-Gonzalez L, Torres-Montes A, Baranda L, de la Fuente H, Rosenstein Y . Expression of CD64 as a potential marker of neonatal sepsis. Pediatr Allergy Immunol. 2002; 13(5):319-27. DOI: 10.1034/j.1399-3038.2002.01064.x. View

14.

Schelonka R, Chai M, Yoder B, Hensley D, Brockett R, Ascher D . Volume of blood required to detect common neonatal pathogens. J Pediatr. 1996; 129(2):275-8. DOI: 10.1016/s0022-3476(96)70254-8. View

15.

Martin H, Olander B, Norman M . Reactive hyperemia and interleukin 6, interleukin 8, and tumor necrosis factor-alpha in the diagnosis of early-onset neonatal sepsis. Pediatrics. 2001; 108(4):E61. DOI: 10.1542/peds.108.4.e61. View

16.

Mehr S, Doyle L . Cytokines as markers of bacterial sepsis in newborn infants: a review. Pediatr Infect Dis J. 2000; 19(9):879-87. DOI: 10.1097/00006454-200009000-00014. View

17.

Hotoura E, Giapros V, Kostoula A, Spyrou P, Andronikou S . Pre-inflammatory mediators and lymphocyte subpopulations in preterm neonates with sepsis. Inflammation. 2011; 35(3):1094-101. DOI: 10.1007/s10753-011-9416-3. View

18.

Stocker M, van Herk W, El Helou S, Dutta S, Fontana M, Schuerman F . Procalcitonin-guided decision making for duration of antibiotic therapy in neonates with suspected early-onset sepsis: a multicentre, randomised controlled trial (NeoPIns). Lancet. 2017; 390(10097):871-881. DOI: 10.1016/S0140-6736(17)31444-7. View

19.

Hornik C, Fort P, Clark R, Watt K, Benjamin Jr D, Smith P . Early and late onset sepsis in very-low-birth-weight infants from a large group of neonatal intensive care units. Early Hum Dev. 2012; 88 Suppl 2:S69-74. PMC: 3513766. DOI: 10.1016/S0378-3782(12)70019-1. View

20.

Bender L, Thaarup J, Varming K, Krarup H, Ellermann-Eriksen S, Ebbesen F . Early and late markers for the detection of early-onset neonatal sepsis. Dan Med Bull. 2009; 55(4):219-23. View